| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 110 | 2025 | 273 | 16.740 |
Why?
|
| Knee Joint | 53 | 2025 | 173 | 6.720 |
Why?
|
| Arthroplasty, Replacement, Knee | 23 | 2025 | 153 | 4.810 |
Why?
|
| Osteoarthritis | 16 | 2023 | 103 | 4.140 |
Why?
|
| Osteoarthritis, Hip | 21 | 2023 | 62 | 3.520 |
Why?
|
| Cartilage, Articular | 26 | 2023 | 64 | 3.100 |
Why?
|
| Chronic Pain | 8 | 2025 | 149 | 2.350 |
Why?
|
| Synovitis | 10 | 2022 | 26 | 2.140 |
Why?
|
| Magnetic Resonance Imaging | 48 | 2025 | 3835 | 1.970 |
Why?
|
| Arthralgia | 11 | 2024 | 68 | 1.540 |
Why?
|
| Disease Progression | 35 | 2024 | 2225 | 1.400 |
Why?
|
| Pain | 21 | 2024 | 456 | 1.340 |
Why?
|
| Patient Preference | 4 | 2017 | 141 | 1.330 |
Why?
|
| Aged | 97 | 2025 | 21409 | 1.290 |
Why?
|
| Pain Management | 8 | 2025 | 196 | 1.270 |
Why?
|
| Middle Aged | 104 | 2025 | 28971 | 1.210 |
Why?
|
| Pain Measurement | 21 | 2025 | 354 | 1.190 |
Why?
|
| Rheumatic Diseases | 3 | 2019 | 73 | 1.100 |
Why?
|
| Joints | 4 | 2016 | 26 | 1.090 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2024 | 23 | 1.000 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2025 | 215 | 0.990 |
Why?
|
| Exercise | 10 | 2023 | 857 | 0.880 |
Why?
|
| Humans | 149 | 2025 | 132088 | 0.880 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 480 | 0.850 |
Why?
|
| Male | 108 | 2025 | 64937 | 0.850 |
Why?
|
| Osteoporosis | 2 | 2022 | 136 | 0.820 |
Why?
|
| Radiography | 19 | 2025 | 819 | 0.800 |
Why?
|
| Exercise Therapy | 5 | 2020 | 182 | 0.770 |
Why?
|
| Female | 101 | 2025 | 70727 | 0.770 |
Why?
|
| Severity of Illness Index | 21 | 2025 | 3093 | 0.720 |
Why?
|
| Hand Joints | 3 | 2020 | 6 | 0.720 |
Why?
|
| Diphosphonates | 1 | 2021 | 43 | 0.700 |
Why?
|
| Antirheumatic Agents | 3 | 2019 | 122 | 0.690 |
Why?
|
| Rheumatology | 4 | 2023 | 129 | 0.680 |
Why?
|
| Bone Density Conservation Agents | 1 | 2021 | 56 | 0.680 |
Why?
|
| Patient Satisfaction | 4 | 2012 | 482 | 0.680 |
Why?
|
| Arthritis | 2 | 2019 | 86 | 0.670 |
Why?
|
| Longitudinal Studies | 18 | 2024 | 1491 | 0.670 |
Why?
|
| Health Status Disparities | 2 | 2021 | 256 | 0.660 |
Why?
|
| Walking | 7 | 2023 | 234 | 0.640 |
Why?
|
| Socioeconomic Factors | 8 | 2019 | 898 | 0.640 |
Why?
|
| Menisci, Tibial | 9 | 2021 | 38 | 0.640 |
Why?
|
| Risk Assessment | 7 | 2021 | 3736 | 0.630 |
Why?
|
| Platelet-Rich Plasma | 1 | 2019 | 19 | 0.610 |
Why?
|
| Opportunistic Infections | 1 | 2019 | 79 | 0.600 |
Why?
|
| Bone Marrow | 5 | 2016 | 327 | 0.590 |
Why?
|
| Interleukins | 1 | 2019 | 129 | 0.580 |
Why?
|
| Wrist Joint | 2 | 2022 | 28 | 0.580 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 87 | 0.580 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 3762 | 0.580 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 186 | 0.560 |
Why?
|
| Analgesics, Opioid | 6 | 2022 | 471 | 0.560 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 305 | 0.540 |
Why?
|
| Glucosamine | 2 | 2014 | 12 | 0.530 |
Why?
|
| Quality of Life | 5 | 2025 | 2137 | 0.520 |
Why?
|
| Osteophyte | 4 | 2022 | 7 | 0.510 |
Why?
|
| Diagnostic Imaging | 2 | 2021 | 314 | 0.500 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2024 | 293 | 0.500 |
Why?
|
| Drug Overdose | 3 | 2022 | 74 | 0.480 |
Why?
|
| United States | 32 | 2023 | 11659 | 0.480 |
Why?
|
| Bone Marrow Diseases | 2 | 2012 | 41 | 0.470 |
Why?
|
| Health Services Accessibility | 4 | 2017 | 668 | 0.470 |
Why?
|
| Psychotherapy | 2 | 2017 | 247 | 0.450 |
Why?
|
| Surgeons | 3 | 2023 | 286 | 0.450 |
Why?
|
| Arthroplasty, Replacement, Hip | 5 | 2011 | 113 | 0.440 |
Why?
|
| Veterans | 8 | 2022 | 1757 | 0.440 |
Why?
|
| Logistic Models | 13 | 2019 | 1838 | 0.430 |
Why?
|
| Overweight | 2 | 2022 | 383 | 0.420 |
Why?
|
| Tibia | 6 | 2022 | 80 | 0.420 |
Why?
|
| Cohort Studies | 18 | 2024 | 5165 | 0.420 |
Why?
|
| Disability Evaluation | 4 | 2020 | 198 | 0.410 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1029 | 0.410 |
Why?
|
| Motor Activity | 6 | 2015 | 523 | 0.410 |
Why?
|
| Cartilage Diseases | 3 | 2022 | 15 | 0.400 |
Why?
|
| Risk Factors | 23 | 2023 | 10942 | 0.390 |
Why?
|
| Prospective Studies | 24 | 2023 | 6567 | 0.390 |
Why?
|
| Time Factors | 15 | 2021 | 6448 | 0.380 |
Why?
|
| Leisure Activities | 1 | 2012 | 10 | 0.380 |
Why?
|
| Arthritis, Juvenile | 1 | 2012 | 42 | 0.370 |
Why?
|
| Internet | 2 | 2014 | 405 | 0.370 |
Why?
|
| Femur | 6 | 2022 | 74 | 0.340 |
Why?
|
| Sleep Wake Disorders | 3 | 2020 | 197 | 0.340 |
Why?
|
| Treatment Outcome | 14 | 2025 | 13029 | 0.340 |
Why?
|
| Aged, 80 and over | 20 | 2022 | 7103 | 0.330 |
Why?
|
| Recovery of Function | 5 | 2020 | 461 | 0.330 |
Why?
|
| Tibial Meniscus Injuries | 3 | 2016 | 31 | 0.310 |
Why?
|
| Healthcare Disparities | 4 | 2019 | 487 | 0.290 |
Why?
|
| Muscle Strength | 3 | 2013 | 84 | 0.290 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2021 | 1247 | 0.280 |
Why?
|
| Acupuncture Therapy | 1 | 2007 | 13 | 0.270 |
Why?
|
| Physician-Patient Relations | 2 | 2011 | 449 | 0.270 |
Why?
|
| Cartilage | 4 | 2022 | 51 | 0.270 |
Why?
|
| Sex Factors | 4 | 2020 | 1353 | 0.270 |
Why?
|
| Electronic Mail | 1 | 2007 | 43 | 0.270 |
Why?
|
| Joint Prosthesis | 3 | 2008 | 18 | 0.260 |
Why?
|
| Prejudice | 2 | 2021 | 38 | 0.260 |
Why?
|
| Gait | 3 | 2017 | 142 | 0.260 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 85 | 0.260 |
Why?
|
| Activities of Daily Living | 5 | 2018 | 427 | 0.250 |
Why?
|
| Scleroderma, Diffuse | 2 | 2016 | 4 | 0.240 |
Why?
|
| Odds Ratio | 6 | 2023 | 1253 | 0.230 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2025 | 22 | 0.230 |
Why?
|
| Self Efficacy | 2 | 2020 | 209 | 0.220 |
Why?
|
| Neoplasms | 1 | 2019 | 2954 | 0.220 |
Why?
|
| Adult | 22 | 2024 | 31573 | 0.220 |
Why?
|
| Perception | 2 | 2011 | 235 | 0.220 |
Why?
|
| Ligaments, Articular | 1 | 2024 | 22 | 0.220 |
Why?
|
| Catastrophization | 2 | 2025 | 19 | 0.220 |
Why?
|
| Predictive Value of Tests | 10 | 2021 | 2320 | 0.220 |
Why?
|
| Linear Models | 6 | 2018 | 713 | 0.220 |
Why?
|
| Case-Control Studies | 12 | 2022 | 3418 | 0.220 |
Why?
|
| Patient Selection | 3 | 2025 | 737 | 0.220 |
Why?
|
| Pressure | 1 | 2024 | 131 | 0.210 |
Why?
|
| Incidence | 8 | 2022 | 3381 | 0.210 |
Why?
|
| Cachexia | 1 | 2024 | 55 | 0.210 |
Why?
|
| Cadaver | 1 | 2024 | 119 | 0.210 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.210 |
Why?
|
| Actigraphy | 3 | 2019 | 48 | 0.210 |
Why?
|
| Synovial Membrane | 2 | 2014 | 26 | 0.210 |
Why?
|
| Obesity | 4 | 2022 | 2392 | 0.210 |
Why?
|
| Isometric Contraction | 2 | 2013 | 23 | 0.210 |
Why?
|
| Hip Prosthesis | 2 | 2005 | 10 | 0.210 |
Why?
|
| Focus Groups | 1 | 2004 | 224 | 0.210 |
Why?
|
| Resistance Training | 1 | 2023 | 29 | 0.210 |
Why?
|
| Self Report | 4 | 2019 | 549 | 0.200 |
Why?
|
| Biomechanical Phenomena | 7 | 2021 | 259 | 0.200 |
Why?
|
| Prevalence | 7 | 2020 | 2659 | 0.200 |
Why?
|
| Crystal Arthropathies | 1 | 2022 | 5 | 0.200 |
Why?
|
| Hypesthesia | 1 | 2022 | 11 | 0.200 |
Why?
|
| Analgesics | 2 | 2021 | 127 | 0.190 |
Why?
|
| Wrist | 1 | 2022 | 26 | 0.190 |
Why?
|
| Quadriceps Muscle | 2 | 2013 | 16 | 0.190 |
Why?
|
| Medicare | 3 | 2021 | 448 | 0.190 |
Why?
|
| Knee | 3 | 2014 | 22 | 0.190 |
Why?
|
| Bayes Theorem | 2 | 2021 | 311 | 0.190 |
Why?
|
| Polymethacrylic Acids | 1 | 2022 | 5 | 0.190 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 56 | 0.190 |
Why?
|
| Bone Diseases | 1 | 2022 | 46 | 0.190 |
Why?
|
| Phenotype | 3 | 2022 | 4531 | 0.190 |
Why?
|
| Sarcopenia | 1 | 2022 | 57 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2024 | 142 | 0.180 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 48 | 0.180 |
Why?
|
| Patella | 2 | 2019 | 28 | 0.180 |
Why?
|
| Adipose Tissue | 3 | 2022 | 504 | 0.180 |
Why?
|
| Calcinosis | 1 | 2022 | 192 | 0.170 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 90 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 386 | 0.170 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2022 | 70 | 0.170 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2021 | 27 | 0.170 |
Why?
|
| Fibula | 1 | 2020 | 20 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2022 | 205 | 0.170 |
Why?
|
| Foundations | 1 | 2020 | 22 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2016 | 1227 | 0.160 |
Why?
|
| Surveys and Questionnaires | 8 | 2024 | 3990 | 0.160 |
Why?
|
| Swimming | 1 | 2019 | 29 | 0.160 |
Why?
|
| Football | 1 | 2020 | 36 | 0.160 |
Why?
|
| Health Status | 3 | 2019 | 402 | 0.160 |
Why?
|
| Reproducibility of Results | 11 | 2018 | 3014 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2024 | 17423 | 0.160 |
Why?
|
| Gout | 1 | 2022 | 167 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2014 | 828 | 0.150 |
Why?
|
| Dermatologic Agents | 1 | 2019 | 30 | 0.150 |
Why?
|
| Nonprescription Drugs | 1 | 2019 | 54 | 0.150 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 35 | 0.150 |
Why?
|
| Algorithms | 3 | 2019 | 1728 | 0.150 |
Why?
|
| Veterans Health | 1 | 2021 | 174 | 0.150 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 64 | 0.150 |
Why?
|
| Sleep | 2 | 2020 | 374 | 0.150 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 5411 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 155 | 0.150 |
Why?
|
| Running | 1 | 2018 | 33 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 340 | 0.140 |
Why?
|
| Sucrose | 1 | 2018 | 37 | 0.140 |
Why?
|
| Hyperphosphatemia | 1 | 2018 | 19 | 0.140 |
Why?
|
| Genu Varum | 1 | 2017 | 1 | 0.140 |
Why?
|
| Pediatrics | 1 | 2007 | 1213 | 0.140 |
Why?
|
| Ferric Compounds | 1 | 2018 | 41 | 0.140 |
Why?
|
| Inflammation | 2 | 2022 | 1517 | 0.140 |
Why?
|
| Double-Blind Method | 3 | 2022 | 1659 | 0.140 |
Why?
|
| Muscle, Skeletal | 4 | 2024 | 1033 | 0.130 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 921 | 0.130 |
Why?
|
| Patellofemoral Joint | 2 | 2014 | 6 | 0.130 |
Why?
|
| Depression | 4 | 2021 | 1333 | 0.130 |
Why?
|
| Communication | 3 | 2011 | 544 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2019 | 327 | 0.130 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2016 | 12 | 0.130 |
Why?
|
| Hip Joint | 1 | 2016 | 47 | 0.130 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2016 | 23 | 0.130 |
Why?
|
| Single-Blind Method | 2 | 2017 | 243 | 0.130 |
Why?
|
| Chronic Disease | 3 | 2012 | 1236 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2018 | 283 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 74 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2017 | 143 | 0.120 |
Why?
|
| Bone Density | 2 | 2018 | 367 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2016 | 129 | 0.120 |
Why?
|
| Machine Learning | 1 | 2019 | 346 | 0.110 |
Why?
|
| Image Enhancement | 3 | 2010 | 173 | 0.110 |
Why?
|
| Atlases as Topic | 1 | 2014 | 17 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 613 | 0.110 |
Why?
|
| Attitude to Health | 2 | 2007 | 259 | 0.110 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 1436 | 0.110 |
Why?
|
| Models, Statistical | 2 | 2014 | 492 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2011 | 234 | 0.110 |
Why?
|
| Exercise Test | 2 | 2015 | 259 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 309 | 0.100 |
Why?
|
| Mobility Limitation | 1 | 2013 | 33 | 0.100 |
Why?
|
| Treatment Refusal | 2 | 2016 | 80 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2016 | 571 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2023 | 136 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 357 | 0.090 |
Why?
|
| Anemia | 1 | 2016 | 350 | 0.090 |
Why?
|
| Housing for the Elderly | 1 | 2011 | 1 | 0.090 |
Why?
|
| Biomarkers | 5 | 2023 | 3407 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2014 | 698 | 0.090 |
Why?
|
| Bone Cysts | 1 | 2011 | 3 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1396 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2013 | 1450 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2012 | 91 | 0.090 |
Why?
|
| Adaptation, Psychological | 2 | 2017 | 446 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2012 | 335 | 0.090 |
Why?
|
| Pennsylvania | 4 | 2013 | 61 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 332 | 0.090 |
Why?
|
| Bursitis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Popliteal Cyst | 1 | 2010 | 3 | 0.090 |
Why?
|
| Acceleration | 1 | 2010 | 27 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 132 | 0.080 |
Why?
|
| Accelerometry | 3 | 2017 | 64 | 0.080 |
Why?
|
| Professional-Patient Relations | 1 | 2011 | 93 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2013 | 242 | 0.080 |
Why?
|
| Clinical Trials as Topic | 3 | 2025 | 1163 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2011 | 91 | 0.080 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 79 | 0.080 |
Why?
|
| Bone Malalignment | 1 | 2010 | 4 | 0.080 |
Why?
|
| Risk | 3 | 2023 | 760 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2010 | 40 | 0.080 |
Why?
|
| Edema | 1 | 2011 | 143 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 853 | 0.080 |
Why?
|
| Professional Competence | 1 | 2011 | 95 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 896 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 951 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 219 | 0.080 |
Why?
|
| Medicaid | 2 | 2022 | 251 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1828 | 0.080 |
Why?
|
| Thermography | 1 | 2008 | 12 | 0.070 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 688 | 0.070 |
Why?
|
| Adiposity | 2 | 2024 | 208 | 0.070 |
Why?
|
| Arthrography | 2 | 2018 | 6 | 0.070 |
Why?
|
| Ohio | 2 | 2011 | 85 | 0.070 |
Why?
|
| Databases as Topic | 1 | 2007 | 76 | 0.070 |
Why?
|
| Age Factors | 3 | 2012 | 2913 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 9959 | 0.070 |
Why?
|
| Prognosis | 5 | 2016 | 5010 | 0.070 |
Why?
|
| Telephone | 1 | 2007 | 123 | 0.070 |
Why?
|
| Symptom Assessment | 2 | 2018 | 111 | 0.060 |
Why?
|
| Knee Prosthesis | 2 | 2005 | 17 | 0.060 |
Why?
|
| Philadelphia | 2 | 2021 | 27 | 0.060 |
Why?
|
| Emergencies | 1 | 2007 | 186 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2007 | 1455 | 0.060 |
Why?
|
| Adolescent | 6 | 2019 | 20568 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2851 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2017 | 309 | 0.060 |
Why?
|
| Hip | 1 | 2004 | 19 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 574 | 0.060 |
Why?
|
| United Kingdom | 2 | 2016 | 235 | 0.060 |
Why?
|
| Religion | 1 | 2004 | 49 | 0.050 |
Why?
|
| Thigh | 1 | 2024 | 51 | 0.050 |
Why?
|
| Gardening | 1 | 2024 | 17 | 0.050 |
Why?
|
| Child | 4 | 2019 | 25793 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2007 | 511 | 0.050 |
Why?
|
| Research Design | 2 | 2018 | 741 | 0.050 |
Why?
|
| ROC Curve | 2 | 2017 | 601 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3352 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 266 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 103 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2007 | 1057 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2002 | 26 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 40 | 0.050 |
Why?
|
| Uric Acid | 1 | 2022 | 110 | 0.050 |
Why?
|
| Health Services for the Aged | 1 | 2002 | 38 | 0.050 |
Why?
|
| Social Perception | 1 | 2002 | 56 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2014 | 195 | 0.040 |
Why?
|
| Organ Size | 2 | 2013 | 449 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2005 | 568 | 0.040 |
Why?
|
| Unemployment | 1 | 2021 | 23 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 18 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2022 | 124 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 2146 | 0.040 |
Why?
|
| Injections, Intra-Articular | 1 | 2020 | 33 | 0.040 |
Why?
|
| Sexism | 1 | 2021 | 43 | 0.040 |
Why?
|
| Streptococcaceae | 1 | 2000 | 2 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2004 | 386 | 0.040 |
Why?
|
| Racism | 1 | 2021 | 42 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 249 | 0.040 |
Why?
|
| Observer Variation | 2 | 2011 | 305 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2021 | 166 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 697 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 1170 | 0.040 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2000 | 79 | 0.040 |
Why?
|
| Medical Informatics Applications | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fitness Trackers | 1 | 2018 | 14 | 0.040 |
Why?
|
| Prescriptions | 1 | 2019 | 44 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2011 | 345 | 0.040 |
Why?
|
| Mental Health | 1 | 2022 | 371 | 0.040 |
Why?
|
| X-Rays | 1 | 2018 | 31 | 0.040 |
Why?
|
| Phosphorus | 1 | 2018 | 61 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2018 | 203 | 0.030 |
Why?
|
| Poverty | 1 | 2021 | 446 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2022 | 993 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2015 | 1695 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 280 | 0.030 |
Why?
|
| Walk Test | 1 | 2016 | 29 | 0.030 |
Why?
|
| North America | 1 | 2017 | 264 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 94 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 2018 | 137 | 0.030 |
Why?
|
| RNA Polymerase III | 1 | 2016 | 41 | 0.030 |
Why?
|
| Tenosynovitis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Arthritis, Gouty | 1 | 2015 | 6 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 561 | 0.030 |
Why?
|
| Arthritis, Psoriatic | 1 | 2015 | 14 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2000 | 317 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 57 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 82 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2018 | 360 | 0.030 |
Why?
|
| Protective Factors | 1 | 2015 | 90 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 451 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 186 | 0.030 |
Why?
|
| Time | 1 | 2014 | 98 | 0.030 |
Why?
|
| Access to Information | 1 | 2014 | 45 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 105 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 105 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 172 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2005 | 3143 | 0.030 |
Why?
|
| Community Health Planning | 1 | 2013 | 8 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 147 | 0.020 |
Why?
|
| Chicago | 1 | 2013 | 21 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1295 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2016 | 457 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2013 | 101 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 380 | 0.020 |
Why?
|
| Torque | 1 | 2012 | 8 | 0.020 |
Why?
|
| Tennessee | 1 | 2012 | 35 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 2035 | 0.020 |
Why?
|
| Spin Labels | 1 | 2011 | 21 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2011 | 58 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 34 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 792 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2017 | 791 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 2010 | 22 | 0.020 |
Why?
|
| Ontario | 1 | 2010 | 90 | 0.020 |
Why?
|
| Office Visits | 1 | 2011 | 78 | 0.020 |
Why?
|
| Orthopedics | 1 | 2011 | 78 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 134 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2011 | 147 | 0.020 |
Why?
|
| Arthroscopy | 1 | 2010 | 45 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 77 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 430 | 0.020 |
Why?
|
| Cysts | 1 | 2010 | 97 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 588 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 435 | 0.020 |
Why?
|
| Public Health | 1 | 2011 | 281 | 0.020 |
Why?
|
| Survival Rate | 1 | 2014 | 2194 | 0.020 |
Why?
|
| Spirituality | 1 | 2008 | 50 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1609 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8550 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2007 | 128 | 0.020 |
Why?
|
| Anxiety | 1 | 2013 | 987 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1443 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 437 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 191 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 299 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1301 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 293 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2172 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 2004 | 164 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 293 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 853 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1574 | 0.010 |
Why?
|
| Bacterial Typing Techniques | 1 | 2000 | 104 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2000 | 827 | 0.010 |
Why?
|